Global Search

Search articles, concepts, and chapters

Hatanaka Marcelo

17 articles in GJC

17 articles in GJC

1.

Selective Laser Trabeculoplasty as a Substitute for Medications in Patients with Mild-to-moderate Glaucoma in the Brazilian Public Health System.

Barbosa Leopoldo Ernesto Oiticica, Barboza Wilma Lelis, Guedes Ricardo Paletta, Pereira Clarissa Dos Reis, Susanna Remo, Hatanaka Marcelo

J GlaucomaDec 20233 citationsClinical Trial

This study found SLT effectively reduces IOP and replaces eye drops in mild-to-moderate glaucoma patients in the Brazilian public health system, significantly cutting medication use and costs.

4.

Comparison of Intraocular Pressure Changes During the Water Drinking Test Between Different Fluid Volumes in Patients With Primary Open-angle Glaucoma.

Susanna Carolina N, Susanna Remo, Hatanaka Marcelo, Susanna Bianca N, Susanna Fernanda N, De Moraes Carlos G

J GlaucomaNov 20180 citationsObservational Study

This study found different water drinking test volumes yield similar IOP responses in glaucoma patients, with no significant BMI influence, suggesting flexibility in WDT protocols.

8.

Evaluation of the Efficacy and Safety of the New Susanna Glaucoma Drainage Device in Refractory Glaucomas: Short-term Results.

Biteli Luis G, Prata Tiago S, Gracitelli Carolina P B, Kanadani Fábio N, Villas Boas Flávia, Hatanaka Marcelo et al.

J GlaucomaApr 20174 citationsClinical Trial

The Susanna Glaucoma Drainage Device effectively lowered IOP and medication use in refractory/neovascular glaucoma patients, showing promise as a short-term treatment option with minor complications.

10.

Comparison of the Intraocular Pressure Variation Provoked by Postural Change and by the Water Drinking Test in Primary Open-angle Glaucoma and Normal Patients.

Hatanaka Marcelo, Sakata Lisandro M, Susanna Remo, Nascimento Luisa T F, Vessani Roberto M

J GlaucomaNov 201614 citationsCross-Sectional Study

This study found glaucoma patients have greater IOP increases with postural change and water drinking, but these tests are not interchangeable, highlighting distinct IOP stress responses.

14.

Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.

Hatanaka Marcelo, Reis Alexandre, Sano Milena Eimi, Susanna Remo

J GlaucomaSep 201016 citationsRandomized Controlled Trial

Adding dorzolamide/timolol to latanoprost significantly lowered intraocular pressure further in glaucoma/ocular hypertension patients, providing enhanced pressure reduction for those needing more control.

15.

An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.

Hatanaka Marcelo, Grigera Daniel E, Barbosa Wilma L, Jordao Marcelo, Susanna Remo

J GlaucomaDec 200825 citationsRandomized Controlled Trial

This study found two fixed-combination glaucoma drops (brimonidine/timolol and dorzolamide/timolol) similarly reduced intraocular pressure and were well-tolerated. Both are effective options for glaucoma management.

All 17 articles loaded